BioLife Solutions Files Form S-3 Registration Statement to Register Shares from Completed Acquisitions
BOTHELL, Wash., Sept. 1, 2021 /PRNewswire/ — BioLife Solutions, Inc. (Nasdaq: BLFS) (“BioLife” or the “Company”), a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma…